Sociedad Química y Minera de Chile (SQM) Corporate Presentation summary

Financial performance and business overview

• Last twelve months (LTM) revenues reached $5.5 billion, with adjusted EBITDA of $2.0 billion and a 37% EBITDA margin as of June 30, 2024.

• Second quarter 2024 revenue was $1,294 million, with a gross profit of $384 million and net income of $214 million.

• Q2 2024 adjusted EBITDA was $413 million, with a margin of 32%; year-on-year, revenue and profit metrics declined significantly.

• Lithium and derivatives contributed 59% of gross profit, followed by iodine (28%), specialty plant nutrition (10%), potassium (2%), and industrial chemicals (2%).

• Net financial debt to adjusted EBITDA ratio stood at 1.1x.

Business segment highlights

• Lithium: Record sales volumes (+21% YoY) but average sales prices dropped 63% YoY; LTM gross profit $1.1B.

• Iodine: Sales volumes up 29% YoY, average prices down 6%; LTM gross profit $530M.

• Specialty plant nutrition: Sales volumes up 21% YoY, prices down 13%; LTM gross profit $183M.

• Potassium: Sales volumes up 53% YoY, prices down 28%; LTM gross profit $35M.

• Industrial chemicals: Sales prices up 52% YoY, volumes down 71%; LTM gross profit $34M.

Market position and global presence

• Holds ~18% global lithium market share, ~35% in iodine, ~42% in specialty plant nutrition, and ~62% in industrial chemicals.

• Sales are geographically diversified: Asia & Others (67%), Europe (13%), North America (13%), Latam & Caribbean (4%), Chile (3%).